Thursday, October 21, 2021
News

US CDC panel endorses Pfizer booster shot for elderly, high-risk people

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

US | September 24, 2021 7:16:00 AM IST
Washington [US], September 24 (ANI/Xinhua): A U.S. Centers for Disease Control and Prevention (CDC) advisory panel on Thursday endorsed booster doses of the Pfizer-BioNTech COVID-19 vaccine for Americans aged 65 and older and some adults with certain high risk conditions.

The panel voted 15-0 to recommend a booster dose for Americans age 65 and older and people in long term care facilities. It also fully recommended giving a single booster dose to people between the ages of 50 and 64 with certain high risk conditions, by a vote of 13-2.

On Wednesday, the Food and Drug Administration approved Pfizer boosters for people aged 65 and older or at high-risk. The extra dose would be given once they are at least six months past their last Pfizer shot.

CDC Director Rochelle Walensky is expected to accept the panel's endorsement shortly. (ANI/Xinhua)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE WORLD NEWS
US-FDA's approval of mix and match COVID...
Bhutan PM congratulates India for crossi...
Criminals kidnap at least 30 people in W...
Taliban face hurdles while implementing ...
FDA takes additional actions on use of b...
US couple plead not guilty to espionage,...
More...
 
INDIA WORLD ASIA
Decades worth of experience of Universal...
Thrashed by teacher, Class 7 student die...
3 held for 'raising pro-Pakistan' slogan...
Perform Lakhbir Singh's 'bhog' as per Si...
Gauri Lankesh murder case: SC restores o...
Dr RS Sharma lauds role of CoWIN app in ...
More...    
 
 Top Stories
Auretics Limited uncaps the benefit... 
T20 WC: England need to learn very ... 
Now shortlist vendors for your even... 
This festive season, make gifting s... 
CBDT issues refunds of Rs 92,961 cr... 
Nissei promotes soft ice cream with... 
Indian doctors affirm US study that... 
Achieving over 100-cr Covid vaccina...